Skip to NavigationSkip to content

Pharmafile - Medical Communications

Top Ten most popular articles on Pharmafile.com this week
It’s time for a rundown of the top 10 articles on PharmaFile this past week. The past seven days saw the first and only transdermal patch for...
2019 saw the FDA approve more generic drugs than ever before
Fiscal year 2019 was a record-breaking one, according to the FDA. The US regulator smashed its previous total for annual generic drug approvals...
FDA panel gives positive vote for Shionogi’s Cefiderocol in Urinary Tract Infections
The US FDA has recommended approval for cefiderocol, a novel antibiotic for complicated urinary tract infections, including pyelonephritis, in...
FDA greenlights Genentech's Xofluza for acute, uncomplicated influenza
Roche subsidiary Genentech has announced that its polymerase acidic endonuclease inhibitor Xofluza (baloxavir marboxil) has been awarded FDA...
>> More Medical Communications News Stories

Features

Medical cannabis: Growth by leaps and bounds

In June 2019, Pharmafocus visited the headquarters of cannabis company Canopy Growth in the Canadian town of Smiths Falls. Louis Goss...

>> More Features

Appointments

Gilead appoints Andrew Dickinson as CFO

Gilead Sciences have announced that Andrew Dickinson has been appointed as Chief Financial Officer (CFO) effective 1 November.

Dickinson...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches